FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,400 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 12400 - 12600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.645Pneumococcal Vaccine HD_CN_ Allergyactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.638b.well Adult Tetanus Vaccine CNactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.648bwell COVID Vaccine CN_Metactive2025-04hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7758Adverse Event Severity (TB)active2017-12
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.963Consequence of Adverse Eventactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7596Adverse Event Severity (Malaria)active2019-01
fhir.acme.affiliate-reportR4ValueSet/affiliate-type-vsAffiliate Type ValueSetdraft2025-05hl7
hl7.fhir.us.registry-protocolsR4ValueSet/YesNoYes or Noactivecic2023-11hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3065Age Category (Animal)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3259Age Group (Flu)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7905Age units (ARLN)active2019-01
hl7.fhir.us.davinci-pdexR4ValueSet/ProvenanceAgentTypeProvenance Agent Typeinformativefm2025-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8054Alanine aminotransferase (ALT) Result (Hepatitis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8019Alcohol Use Frequency (Anthrax)active2020-01
hl7.fhir.us.registry-protocolsR4ValueSet/StressTestCath PCI Selected Stress Testactivecic2023-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/barbiturate-medicationsBarbiturate Medicationsactive2025-02hl7
fhir.cdc.opioid-cds-r4R4ValueSet/buprenorphine-and-methadone-medicationsBuprenorphine and Methadone medicationsactive2023-05hl7
fhir.cdc.opioid-cds-r4R4ValueSet/buprenorphine-medicationsBuprenorphine Medicationsactive2025-02hl7
fhir.dicomR4ValueSet/allAll DICOM Controlled Terminology Definitionsactive2025-04hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ISBTConvalescentPlasmaCodeVSISBT Convalescent Plasma Codesdraft2023-08hl7
hl7.fhir.us.icsr-ae-reportingR4ValueSet/ISBTBloodProductCodeVSISBT Blood Product Codesdraft2023-08hl7
hl7.fhir.us.registry-protocolsR4ValueSet/SEattleAnginaQsSeattle Angina Questionsactivecic2023-11hl7
fhir.tx.support.r4R4ValueSet/covid-19-obsCOVID-19 related Observation codesdraft2020-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.13Screening and Assessment Survey Codesactive2024-10hl7
fhir.cdc.opioid-cds-r4R4ValueSet/oxycodone-medicationsOxycodone Medicationsactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6053Lab Test Name (Reportable Conditions)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6054Lab Test Result (Reportable Conditions)active2016-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1190.58Diabetes Medicationsactive2022-03hl7
fhir.tx.support.r4R4ValueSet/covid-19-condCOVID-19 related Condition codesdraft2020-03hl7
hl7.fhir.us.registry-protocolsR4ValueSet/HemodialysisOrPeritonealDialysishemodialysis or peritoneal dialysisactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CardiacArrestCardiac Arrestactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CABGCoronary artery bypass graftingactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/CerebrovascularDiseaseCerebrovascular Diseaseactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/PeripheralArterialOcclusiveDiseasePeripheral Arterial Occlusive Diseaseactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/DiabetesMellitusDiabetes Mellitusactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/DyslipidemiaDyslipidemiaactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/HeartFailureHeart Failure codes from SNOMEDactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/HypertensionHypertensionactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/PercutaneousCoronaryInterventionPCIactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/PriorCABGPrior History of Coronary Artery Bypass Graftactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/HypothermiaInducedInduced Hypothermia Codesactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/OrganDonorSNOMED Valueset of Organ Donor codesactivecic2023-11hl7
hl7.fhir.us.registry-protocolsR4ValueSet/AbnormalElectrocardiacAssessmentAbnormal Electrocardiac Assessmentactivecic2023-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/benzodiazepine-medicationsBenzodiazepine medicationsactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.230All Cancer Directed therapiesactive2024-05hl7
hl7.fhir.us.registry-protocolsR4ValueSet/FamilyPrematureCADFamily History of Premature CADactivecic2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.158Multiple Myeloma Regimen Drugsactive2019-08hl7
fhir.cdc.opioid-cds-r4R4ValueSet/naloxone-medicationsNaloxone medicationsactive2025-02hl7
fhir.cdc.opioid-cds-r4R4ValueSet/cdc-malignant-cancer-conditionsCDC malignant cancer conditionsactive2023-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.226Opioids, Allactive2024-01hl7
fhir.cdc.opioid-cds-r4R4ValueSet/opioid-analgesics-with-ambulatory-misuse-potentialOpioid analgesics with ambulatory misuse potentialactive2025-02hl7
fhir.cdc.opioid-cds-r4R4ValueSet/extended-release-opioid-with-ambulatory-misuse-potentialExtended release opioid with ambulatory misuse potentialactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1053Carbidopa Levodopa Combination (RXNORM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2362Tuberculosis (Ethambutol) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2363Tuberculosis (Isoniazid [INH]) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2364Tuberculosis (Pyrazinamide [PZA]) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2365Tuberculosis (Rifabutin) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2366Tuberculosis (Rifampin) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2367Tuberculosis (Rifapentine) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.741Hepatitis B Immune Globulin (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.747Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.844Tuberculosis (Second Line Drugs for Treatment) (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.991Rifampin (RXNORM)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1594HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1595HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1597HIV Infection (ARV Combination Treatment for HIV) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1598HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1600HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1634Sofosbuvir Velpatasvir Combination (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1912Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1913Penicillin G [Procaine] [Injectable] (RXNORM)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1078Opioid Overdose and Poisoning (Naloxone) (RxNorm)active2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.1618Smallpox Vaccine (RXNORM)active2023-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2142Linezolid (RXNORM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2143Tuberculosis (Pretomanid) (RXNORM)active2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1146.2144Tuberculosis (Bedaquiline) (RXNORM)active2023-01hl7
hl7.fhir.us.davinci-crdR4ValueSet/configTypesCRD Configuration Code Data Types Value Settrial-use4fm2025-07hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-high-dose-rate-technique-vsBrachytherapy High Dose Rate Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-high-dose-rate-electronic-technique-vsBrachytherapy High Dose Rate Electronic Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-low-dose-rate-temporary-technique-vsBrachytherapy Low Dose Rate Temporary Radiation Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-pulsed-dose-rate-technique-vsBrachytherapy Pulsed Dose Rate Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-permanent-seeds-technique-vsBrachytherapy Permanent Seeds Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-brachytherapy-radiopharmaceutical-technique-vsBrachytherapy Radiopharmaceutical Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-carbon-ion-beam-technique-vsCarbon Ion Beam Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-electron-beam-technique-vsElectron Beam Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-neutron-beam-technique-vsNeutron Beam Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-photon-beam-technique-vsPhoton Beam Technique Value Setactive3cic2025-02hl7
hl7.fhir.us.mcodeR4ValueSet/mcode-teleradiotherapy-proton-beam-technique-vsProton Beam Technique Value Setactive3cic2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.6037Industry (Census)active2012-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1096.16Reasons for Interventions Related to Medication Managementactive2022-03hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1026Pregnancy Trimesteractive2008-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1078.558Butalbital analgesicsactive2023-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.789Social Determinants of Health Proceduresactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1196.790Social Determinants of Health Service Requestsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.11Food Insecurity Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.118Health Literacy Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.119Health Literacy Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.122Medical Cost Burden Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.123Medical Cost Burden Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.124Health Insurance Coverage Status Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.125Health Insurance Coverage Status Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.20Homelessness Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.21Homelessness Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.226Digital Literacy Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.227Digital Literacy Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.235Digital Access Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.236Digital Access Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.247Utility Insecurity Proceduresactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.252Utility Insecurity Service Requestsactive2024-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.260Incarceration Status Proceduresactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.261Incarceration Status Service Requestsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.268Language Access Proceduresactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.269Language Access Service Requestsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.27Transportation Insecurity Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.28Transportation Insecurity Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.31Financial Insecurity Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.32Financial Insecurity Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.38Material Hardship Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.39Material Hardship Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.44Housing Instability Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.45Housing Instability Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.52Inadequate Housing Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.53Inadequate Housing Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.56Less Than High School Education Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.57Less Than High School Education Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.59Unemployment Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.60Unemployment Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.67Elder Abuse Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.68Elder Abuse Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.7Food Insecurity Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.87Stress Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.90Veteran Status Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.91Veteran Status Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.92Stress Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.94Social Connection Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.95Social Connection Service Requestsactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.97Intimate Partner Violence Proceduresactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1247.98Intimate Partner Violence Service Requestsactive2024-06hl7
fhir.cdc.opioid-cds-r4R4ValueSet/amphetamines-class-medicationsAmphetamine class medicationsactive2025-02hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.965Amplification and Extraction Kitactive2008-01
hl7.fhir.us.covid19libraryR4ValueSet/covid-19-severity-value-setCOVID-19 Signs and Symptoms Severity Value Setactive2022-07hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-TumorMarginDescriptionVSBC TumorMarginDescriptionVS ValueSetdraft2018-08hl7
hl7.fhir.us.breastcancerR3ValueSet/oncology-Ki-67NuclearAntigenVSBC Ki-67NuclearAntigenVS ValueSetdraft2018-08hl7
signal.core.r4R4ValueSet/servicerequest-orderdetailService Request Order Details Codesdraft1oo2019-10hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7613Job Supervisory Level or Pay Grade (ODH)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7652Mailing Address Indicator (NCHS)active2017-01
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.22.5.306Infectious Diseaseactive2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3124Body Region (Tetanus)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7189Specimen Source (STD)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7554Specimen Collection Site AST (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3285Anatomical Entity (Body Site)active2009-01
hl7.fhir.us.breastcancerR3ValueSet/cimi-element-AnatomicalDirectionVSBC AnatomicalDirectionVS ValueSetdraft2018-08hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.1074Animalactive2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3072Animal Type (FDD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7793Likely Contact (Listeria)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3067Virus Variant Type (Animal Rabies)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3068Animal Species (Animal Rabies)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7971Animal Type (Brucellosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7967Animal Type (Leptospirosis)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7999Animal Type (Anthrax)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.21Annual Physical CPT CN5active2023-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.23Annual Physical CPT for Tax Pair CN5active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.30Annual Physical Codes for Tax Pair CN5active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.22Annual Physical HCPCS CN5active2023-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.17Annual Physical ICD10 CN5active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.16Annual Physical ICD9 CN5active2023-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.24Annual Physical ICD9 for Tax Pair CN5active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.18Annual Physical SNOMED CN5active2023-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1235.19Annual Physical Taxonomy CN5active2024-06hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3125Case Classification Exposure Sourceactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8013Exposure Source (Anthrax)active2020-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3089Interview Statusactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3167Therapy Extended Reason (TB)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3074Case Traced to Carrieractive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3119Acute Convalescent IgG Difference (VPD)active2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3166Cause of Death Related to TBactive2008-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7620Antacids (FDD)active2017-01
hl7.fhir.us.breast-radiologyR4ValueSet/rde1559-depthRDE1559 Depthdraft2022-12hl7
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3212Signs and Symptoms (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3220Disease Type (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3207Lab Test Result Name (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3216Medication Treatment (Anthrax)active2009-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3317Antimicrobial Susceptibility Test Method (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3316Antimicrobial Agent (IPD)active2010-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8036Antibiotic Dose Units (Brucellosis)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7693Antibiotic Received (RIBD)active2021-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.3120Antibiotic Received (Pertussis)active2015-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7619Antibiotics (FDD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7553Specimen Type AST (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7557Susceptibility Test Interpretation (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7704Susceptibility Interpretation (RIBD)active2019-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7701AR Test Method (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7556Susceptibility Test Method (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7559Susceptibility Test Result Quantitative (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7558Susceptibility Test Result Units (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7555Susceptibility Test Type (STD)active2017-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.7700AR Agent (RIBD)active2018-01
us.cdc.phinvadsR4ValueSet/2.16.840.1.114222.4.11.8005Antimicrobials (Anthrax)active2020-01
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.45Endometrial Cancer ICD9active2023-11hl7
fhir.cdc.opioid-cds-r4R4ValueSet/conditions-documenting-substance-misuseConditions documenting substance misuseactive2025-04hl7